227 related articles for article (PubMed ID: 33417176)
21. Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.
Szilagyi A; Xue X
Med Hypotheses; 2018 Jan; 110():31-37. PubMed ID: 29317064
[TBL] [Abstract][Full Text] [Related]
22. The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission.
Jonefjäll B; Simrén M; Öhman L; Lasson A; Svedlund J; Strid H
J Crohns Colitis; 2015 Sep; 9(9):776-83. PubMed ID: 26079726
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis.
Fairbrass KM; Costantino SJ; Gracie DJ; Ford AC
Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1053-1062. PubMed ID: 33010814
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
[TBL] [Abstract][Full Text] [Related]
25. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.
Simrén M; Axelsson J; Gillberg R; Abrahamsson H; Svedlund J; Björnsson ES
Am J Gastroenterol; 2002 Feb; 97(2):389-96. PubMed ID: 11866278
[TBL] [Abstract][Full Text] [Related]
26. Anhedonia in irritable bowel syndrome and in inflammatory bowel diseases and its relationship with abdominal pain.
Carpinelli L; Bucci C; Santonicola A; Zingone F; Ciacci C; Iovino P
Neurogastroenterol Motil; 2019 Mar; 31(3):e13531. PubMed ID: 30628137
[TBL] [Abstract][Full Text] [Related]
27. Effect of Irritable Bowel Syndrome on Sleep Quality and Quality of Life of Inflammatory Bowel Disease in Clinical Remission.
Zargar A; Gooraji SA; Keshavarzi B; Haji Aghamohammadi AA
Int J Prev Med; 2019; 10():10. PubMed ID: 30774844
[TBL] [Abstract][Full Text] [Related]
28. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
[TBL] [Abstract][Full Text] [Related]
29. Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms.
Moraes L; Magnusson MK; Mavroudis G; Polster A; Jonefjäll B; Törnblom H; Sundin J; Simrén M; Strid H; Öhman L
Inflamm Bowel Dis; 2020 May; 26(6):874-884. PubMed ID: 31901089
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life.
Pace F; Molteni P; Bollani S; Sarzi-Puttini P; Stockbrügger R; Bianchi Porro G; Drossman DA
Scand J Gastroenterol; 2003 Oct; 38(10):1031-8. PubMed ID: 14621276
[TBL] [Abstract][Full Text] [Related]
31. The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission.
Hoekman DR; Zeevenhooven J; D'Haens GR; Benninga MA
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1086-1090. PubMed ID: 28639969
[TBL] [Abstract][Full Text] [Related]
32. Sensorineural hearing loss and ulcerative colitis in remission.
Bodh V; Kumar R; Sharma R; Sharma B; Sachdeva A; Azad R
Indian J Gastroenterol; 2022 Apr; 41(2):143-148. PubMed ID: 35247189
[TBL] [Abstract][Full Text] [Related]
33. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
34. [Emotional and personality features of patients with irritable bowel syndrome and bowel inflammatory diseases].
Mnatsakanyan MG; Dyukova GM; Pogromov AP; Tashchyan OV
Klin Med (Mosk); 2016; 94(10):764-9. PubMed ID: 30299020
[TBL] [Abstract][Full Text] [Related]
35. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
[TBL] [Abstract][Full Text] [Related]
36. Frequency of and Factors Associated With Sexual Dysfunction in Patients With Inflammatory Bowel Disease.
Rivière P; Zallot C; Desobry P; Sabaté JM; Vergniol J; Zerbib F; Peyrin-Biroulet L; Laharie D; Poullenot F
J Crohns Colitis; 2017 Oct; 11(11):1347-1352. PubMed ID: 28981625
[TBL] [Abstract][Full Text] [Related]
37. Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms.
Cui X; Wang H; Ye Z; Li Y; Qiu X; Zhang H
BMC Gastroenterol; 2021 Nov; 21(1):433. PubMed ID: 34798830
[TBL] [Abstract][Full Text] [Related]
38. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G
Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
[TBL] [Abstract][Full Text] [Related]
39. Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.
Ledergerber M; Lang BM; Heinrich H; Biedermann L; Begré S; Zeitz J; Krupka N; Rickenbacher A; Turina M; Greuter T; Schreiner P; Roth R; Siebenhüner A; Vavricka SR; Rogler G; Beerenwinkel N; Misselwitz B;
BMC Gastroenterol; 2021 Feb; 21(1):53. PubMed ID: 33546600
[TBL] [Abstract][Full Text] [Related]
40. Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis.
Barratt SM; Leeds JS; Robinson K; Lobo AJ; McAlindon ME; Sanders DS
Dig Dis Sci; 2011 Nov; 56(11):3270-5. PubMed ID: 21695401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
